| 武汉天德生物病理生物芯片系列-BRC1503 | ||||||||||||
| 芯片编号 | BRC1503 | |||||||||||
| 芯片名称 | 乳腺癌,75例,150芯(1.1mm),系列3 | |||||||||||
| 芯片说明 | 乳腺癌组织芯片,系列3,不与BRC1501,BRC1502,BRC1504 到BRC15011重复,150芯,包括正常/良性(5例)和癌(70例)组织提供分级,TNM分期,和AR,ER,PR,HER2,P53,EGFR,Ki67 IHC数据。 | |||||||||||
| 点数: | 150芯 | |||||||||||
| 例数: | 75例 | |||||||||||
| 组织固定方式: | 福尔马林固定24h | |||||||||||
| QA/QC: | HE染色和IHC染色 | |||||||||||
| 应用: | 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。 | |||||||||||
| 注意事项: | 1.收到产品后请常温保存,并在24个月内使用,2.请在实验前60°烤片30分钟,3.请选择温和的修复方式,以免造成组织脱落。 | |||||||||||
| Array Name | Array position | Order | Sex | Age | Anatomic site | Pathology | Nature | Grade | Stage (TNM) | Intensity | Percentage | Comment |
| BRC1503 | A01 | 1 | F | 26 | Breast | Normal | Normal | 0 | ||||
| BRC1503 | A02 | 2 | F | 45 | Breast | Adenosis | Benign | 0 | ||||
| BRC1503 | A03 | 3 | F | 35 | Breast | Adenosis | Benign | 0 | ||||
| BRC1503 | A04 | 4 | F | 23 | Breast | Fibroadenoma | Benign | 0 | ||||
| BRC1503 | A05 | 5 | F | 40 | Breast | Fibrocystic disease | Benign | 0 | ||||
| BRC1503 | A06 | 6 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | A07 | 7 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | A08 | 8 | F | 32 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 5% | |
| BRC1503 | A09 | 9 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | A10 | 10 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 8% | |
| BRC1503 | A11 | 11 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | III | T2N0M0 | 1 | 8% | |
| BRC1503 | A12 | 12 | F | 63 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | A13 | 13 | F | 42 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N0M0 | 1 | 8% | |
| BRC1503 | A14 | 14 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | A15 | 15 | F | 34 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | B01 | 16 | F | 26 | Breast | Normal | Normal | 0 | ||||
| BRC1503 | B02 | 17 | F | 45 | Breast | Adenosis | Benign | 0 | ||||
| BRC1503 | B03 | 18 | F | 35 | Breast | Adenosis | Benign | 0 | ||||
| BRC1503 | B04 | 19 | F | 23 | Breast | Fibroadenoma | Benign | 0 | ||||
| BRC1503 | B05 | 20 | F | 40 | Breast | Fibrocystic disease | Benign | 0 | ||||
| BRC1503 | B06 | 21 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | B07 | 22 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | B08 | 23 | F | 32 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 5% | |
| BRC1503 | B09 | 24 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | B10 | 25 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 8% | |
| BRC1503 | B11 | 26 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | III | T2N0M0 | 1 | 8% | |
| BRC1503 | B12 | 27 | F | 63 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | B13 | 28 | F | 42 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N0M0 | 1 | 8% | |
| BRC1503 | B14 | 29 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | B15 | 30 | F | 34 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | C01 | 31 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | C02 | 32 | F | 25 | Breast | Lobular carcinoma in situ | Malignant | TisN0M0 | 2 | 15% | ||
| BRC1503 | C03 | 33 | F | 45 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N0M0 | 0.5 | ||
| BRC1503 | C04 | 34 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | C05 | 35 | F | 38 | Breast | Invasive ductal carcinoma | Malignant | I~II | T2N0M0 | 0 | ||
| BRC1503 | C06 | 36 | F | 70 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 30% | |
| BRC1503 | C07 | 37 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 0 | ||
| BRC1503 | C08 | 38 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | TisN0M0 | 0 | |||
| BRC1503 | C09 | 39 | F | 68 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 2 | 20% | |
| BRC1503 | C10 | 40 | F | 68 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 1 | 5% | |
| BRC1503 | C11 | 41 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | C12 | 42 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | C13 | 43 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 0 | ||
| BRC1503 | C14 | 44 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 1 | 5% | |
| BRC1503 | C15 | 45 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | D01 | 46 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | D02 | 47 | F | 25 | Breast | Lobular carcinoma in situ | Malignant | TisN0M0 | 2 | 15% | ||
| BRC1503 | D03 | 48 | F | 45 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N0M0 | 0.5 | ||
| BRC1503 | D04 | 49 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | D05 | 50 | F | 38 | Breast | Invasive ductal carcinoma | Malignant | I~II | T2N0M0 | 0 | ||
| BRC1503 | D06 | 51 | F | 70 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 30% | |
| BRC1503 | D07 | 52 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 0 | ||
| BRC1503 | D08 | 53 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | TisN0M0 | 0 | |||
| BRC1503 | D09 | 54 | M | 68 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 2 | 20% | |
| BRC1503 | D10 | 55 | F | 68 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 1 | 5% | |
| BRC1503 | D11 | 56 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | D12 | 57 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | D13 | 58 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N1M0 | 0 | ||
| BRC1503 | D14 | 59 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 1 | 5% | |
| BRC1503 | D15 | 60 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | E01 | 61 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 5% | |
| BRC1503 | E02 | 62 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | E03 | 63 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 1 | 8% | |
| BRC1503 | E04 | 64 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 20% | |
| BRC1503 | E05 | 65 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | E06 | 66 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 2 | 20% | |
| BRC1503 | E07 | 67 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 1 | 8% | |
| BRC1503 | E08 | 68 | F | 41 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 25% | |
| BRC1503 | E09 | 69 | F | 61 | Breast | Lobular carcinoma in situ | Malignant | TisN0M0 | 1 | 8% | ||
| BRC1503 | E10 | 70 | F | 86 | Breast | Invasive carcinoma with apocrine features | Malignant | III | T2N0M0 | 1 | 5% | |
| BRC1503 | E11 | 71 | F | 34 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N3M0 | 0 | ||
| BRC1503 | E12 | 72 | F | 64 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | E13 | 73 | F | 35 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | E14 | 74 | F | 44 | Breast | Invasive tubular carcinoma | Malignant | II | T2N1M0 | 1 | 8% | |
| BRC1503 | E15 | 75 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | F01 | 76 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 5% | |
| BRC1503 | F02 | 77 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | F03 | 78 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 1 | 8% | |
| BRC1503 | F04 | 79 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 20% | |
| BRC1503 | F05 | 80 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | F06 | 81 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 2 | 20% | |
| BRC1503 | F07 | 82 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 1 | 8% | |
| BRC1503 | F08 | 83 | F | 41 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 25% | |
| BRC1503 | F09 | 84 | F | 61 | Breast | Lobular carcinoma in situ | Malignant | TisN0M0 | 1 | 8% | ||
| BRC1503 | F10 | 85 | F | 86 | Breast | Invasive carcinoma with apocrine features | Malignant | III | T2N0M0 | 1 | 5% | |
| BRC1503 | F11 | 86 | F | 34 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N3M0 | 0 | ||
| BRC1503 | F12 | 87 | F | 64 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | F13 | 88 | F | 35 | Breast | Invasive lobular carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | F14 | 89 | F | 44 | Breast | Invasive tubular carcinoma | Malignant | II | T2N1M0 | 1 | 8% | |
| BRC1503 | F15 | 90 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | G01 | 91 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | G02 | 92 | F | 58 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | G03 | 93 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | G04 | 94 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | G05 | 95 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 5% | |
| BRC1503 | G06 | 96 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | G07 | 97 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 15% | |
| BRC1503 | G08 | 98 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T4N0M0 | 1 | 8% | |
| BRC1503 | G09 | 99 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2.5 | 50% | |
| BRC1503 | G10 | 100 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | G11 | 101 | F | 34 | Breast | Intra-ductal carcinoma | Malignant | TisN0M0 | 2 | 15% | ||
| BRC1503 | G12 | 102 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 15% | |
| BRC1503 | G13 | 103 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | G14 | 104 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | G15 | 105 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 | 1 | 5% | |
| BRC1503 | H01 | 106 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | H02 | 107 | F | 58 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | H03 | 108 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | H04 | 109 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | H05 | 110 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 1 | 5% | |
| BRC1503 | H06 | 111 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | H07 | 112 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 15% | |
| BRC1503 | H08 | 113 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T4N0M0 | 1 | 8% | |
| BRC1503 | H09 | 114 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2.5 | 50% | |
| BRC1503 | H10 | 115 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 8% | |
| BRC1503 | H11 | 116 | F | 34 | Breast | Intra-ductal carcinoma | Malignant | TisN0M0 | 2 | 15% | ||
| BRC1503 | H12 | 117 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 15% | |
| BRC1503 | H13 | 118 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | H14 | 119 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | H15 | 120 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 | 1 | 5% | |
| BRC1503 | I01 | 121 | F | 34 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | I02 | 122 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 2 | 35% | |
| BRC1503 | I03 | 123 | F | 76 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 5% | |
| BRC1503 | I04 | 124 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 25% | |
| BRC1503 | I05 | 125 | F | 33 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | I06 | 126 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 15% | |
| BRC1503 | I07 | 127 | F | 72 | Breast | Invasive ductal carcinoma | Malignant | II~III | T4N0M0 | 1 | 8% | |
| BRC1503 | I08 | 128 | F | 35 | Breast | Invasive ductal carcinoma | Malignant | I~II | T3N1M0 | 2 | 20% | |
| BRC1503 | I09 | 129 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | I10 | 130 | F | 37 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 20% | |
| BRC1503 | I11 | 131 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N0M0 | 0 | ||
| BRC1503 | I12 | 132 | F | 52 | Breast | Invasive lobular carcinoma | Malignant | II~III | T1N0M0 | 2.5 | 50% | |
| BRC1503 | I13 | 133 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 3 | 60% | |
| BRC1503 | I14 | 134 | F | 70 | Breast | Tubular mixed carcinoma | Malignant | II~III | T1N0M0 | 3 | 60% | |
| BRC1503 | I15 | 135 | F | 44 | Breast | Intra-ductal carcinoma | Malignant | TisN0M0 | 0 | |||
| BRC1503 | J01 | 136 | F | 34 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 0 | ||
| BRC1503 | J02 | 137 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II~III | T1N0M0 | 2 | 35% | |
| BRC1503 | J03 | 138 | F | 76 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 1 | 5% | |
| BRC1503 | J04 | 139 | F | 39 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 25% | |
| BRC1503 | J05 | 140 | F | 33 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N1M0 | 0 | ||
| BRC1503 | J06 | 141 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 2 | 15% | |
| BRC1503 | J07 | 142 | F | 72 | Breast | Invasive ductal carcinoma | Malignant | II~III | T4N0M0 | 1 | 8% | |
| BRC1503 | J08 | 143 | F | 35 | Breast | Invasive ductal carcinoma | Malignant | I~II | T3N1M0 | 2 | 20% | |
| BRC1503 | J09 | 144 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 0 | ||
| BRC1503 | J10 | 145 | F | 37 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 | 2 | 20% | |
| BRC1503 | J11 | 146 | F | 53 | Breast | Invasive ductal carcinoma | Malignant | II~III | T3N0M0 | 0 | ||
| BRC1503 | J12 | 147 | F | 52 | Breast | Invasive lobular carcinoma | Malignant | II~III | T1N0M0 | 2.5 | 50% | |
| BRC1503 | J13 | 148 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 | 3 | 60% | |
| BRC1503 | J14 | 149 | F | 70 | Breast | Tubular mixed carcinoma | Malignant | II~III | T1N0M0 | 3 | 60% | |
| BRC1503 | J15 | 150 | F | 44 | Breast | Intra-ductal carcinoma | Malignant | TisN0M0 | 0 | |||